5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin and Aura

5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin has been researched along with Aura in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aliwarga, T; Brundage, RC; Cloyd, JC; Goel, V; Leppik, IE; Marino, SE; Remmel, RP	1

Other Studies

1 other study(ies) available for 5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin and Aura

Article	Year
Excretion of the principal urinary metabolites of phenytoin and absolute oral bioavailability determined by use of a stable isotope in patients with epilepsy. Therapeutic drug monitoring, 2011, Volume: 33, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Epilepsy; Female; Humans; Isotope Labeling; Male; Middle Aged; Phenytoin; Young Adult	2011

Article

Year

Excretion of the principal urinary metabolites of phenytoin and absolute oral bioavailability determined by use of a stable isotope in patients with epilepsy.

Therapeutic drug monitoring, 2011, Volume: 33, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Epilepsy; Female; Humans; Isotope Labeling; Male; Middle Aged; Phenytoin; Young Adult

2011